Page 86 - Read Online
P. 86

Page 8 of 19         Corn et al. J Cancer Metastasis Treat 2021;7:41  https://dx.doi.org/10.20517/2394-4722.2021.63

               this process are unknown.


               Tumor types and uptake patterns
                                                                                         [63]
               Papillary thyroid cancer accounts for nearly 90% of all cases of thyroid carcinomas . Primary thyroid
               carcinomas would be expected to make up the majority of thyroid incidentalomas, however it is important
               to recognize that metastases and thyroid lymphomas have also been described. This is significant as it may
               prompt a change in prognosis and treatment. A meta-analysis identified 1.1% of PET-detected thyroid
               incidentalomas to represent metastatic disease and a 19.8% overall malignancy rate (with 15.4% representing
                                        [64]
               papillary thyroid carcinoma) . Metastases to the thyroid were described with solitary focal, multiple focal,
               and diffuse patterns of FDG avidity . Table 2 includes tumor types diagnosed by either cytopathology or
                                              [65]
               histopathology in studies reporting this information.

               IMAGING CHARACTERISTICS
               Although generally uncommon, focal thyroid incidentalomas are reported at higher frequencies than diffuse
               lesions, and the associated rate of malignancy is greater. Therefore, imaging characteristics, such as the
               magnitude of FDG uptake, have been postulated to adjust for malignancy risk.

               Standardized uptake value
               Standardized uptake values (SUV) are commonly reported to quantify the magnitude of FDG uptake on
               PET/CT. Several studies have evaluated the ability of SUV to discriminate malignant from benign thyroid
                                                                max
                                                                              [66]
               incidentalomas with conflicting conclusions (see Table 3). Mitchell et al.  reported that using a SUV
                                                                                                        max
               cutoff value of 5.0 resulted in 60% sensitivity and 91% specificity for detection of malignancy, while
               Boeckmann et al.  proposed a cutoff value of 4.2. Some reports noted a significant difference in SUV
                              [67]
                                                                                                        max
               between malignant and benign lesions (albeit frequently with substantial overlap), while others showed no
               difference at all. Recall that benign and malignant oncocytic/Hürthle cell lesions are known to exhibit high
               FDG-avidity due to an intrinsic mitochondrial defect resulting in inefficient glucose metabolism [22,23] .

               Small tumors, including many thyroid incidentalomas, may not be accurately quantified on PET imaging
                                          [68]
               due to the partial-volume effect . It is generally thought that the limit of resolution for PET/CT uptake is
               5-8 mm, although the partial volume effect may impact SUV values in lesions measuring 2 to 3 times the
               spatial resolution. Measures such as metabolic tumor volume (MTV) have attempted to correct for this
               limitation by accounting for volume, which may allow greater accuracy in the assessment of metabolic
               activity and thus the risk of malignancy. Unfortunately, data regarding these parameters remains
               inconclusive in their ability to discriminate benign from malignant thyroid incidentalomas. A study by
               Ceriani et al.  evaluated functional PET-derived measures and found that malignant lesions had
                           [25]
               significantly higher values of MTV, total lesion glycolysis (TLG = MTV × SUV mean ), SUV , SUV mean , and
                                                                                            max
               SUV . Of these, TLG was the most useful parameter as it correctly identified 79% of lesions (univariate
                   peak
               logistic regression, P < 0.0001).

               The study by Ceriani et al.  also employed radiomic analysis of these lesions, using quantitative data from
                                      [25]
               medical imaging to glean additional information such as shape and texture analysis. A multivariate stepwise
               logistic regression analysis found that TLG, SUV , and shape sphericity remained significant (P < 0.0001).
                                                        max
               All triple-positive tumors were found to be malignant, while 93% of triple-negative lesions were benign. A
               recent study by Aksu et al.  supports these findings with the development of a predictive model combining
                                     [69]
               SUV  and a radionomic parameter noted as GLRLM RLNU . GLRLM describes heterogeneity of the lesion and
                   max
               was found to have the highest AUC value on ROC analysis. The resulting model was found to have a
               sensitivity and specificity of 75% and 81.8%, respectively. Other studies support the utility of these measures
   81   82   83   84   85   86   87   88   89   90   91